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I 
 
RÉSUMÉ 
 
Contexte: En dépit de la preuve substantielle pour l'efficacité générale de la thérapie cognitivo-
comportementale pour le trouble obsessionnel-compulsif (TOC), il existe une controverse à 
propos de l'amélioration de certains déficits neuropsychologiques dans ce trouble. Objectif: Le 
but de cette étude est d'évaluer: 1) la corrélation de la gravité du TOC et les résultats des tests 
neuropsychologiques et 2) l'amélioration clinique et neuropsychologique des patients souffrant de 
TOC qui ont terminé avec succès leur traitement. Méthode: Cette étude évalue les fonctions 
neurocognitives et l'état clinique de 27 participants du groupe TOC et 25 participants du groupe 
témoin. La fonction neurocognitive de chaque participant a été évaluée en utilisant le test de Rey-
Osterreich Figure complexe (RCFT), le test de fluidité D-KEFS et l‘essai Cardebat-D. Nous avons 
également, utilisé l'inventaire d'anxiété de Beck (IAB), l‘Inventaire de dépression de Beck (IDB) et 
l'échelle d'obsession-compulsion de Yale-Brown (Y-BOCS) pour vérifier la présence de l'anxiété et 
de la dépression avec le TOC et la gravité des symptômes chez les patients souffrant de TOC. 
Résultats: Notre étude conclut qu‘il y une différence significative de la fonction de la mémoire 
selon le  score au sous test de copie entre les participants souffrant de TOC et le groupe témoin. 
De plus, nous avons constaté une différence considérable dans le score de rappel immédiat et 
différé du RCFT avant et après le traitement dans le groupe de TOC. Conclusion: En résumé, la 
présente étude a démontré que les patients atteints de TOC ont des troubles cognitifs spécifiques 
et que  la thérapie cognitivo-comportementale serait un traitement qui pourrait améliorer, au 
moins, certaines dysfonctions neurocognitives.  
 
Mots-clés: TOC, les tests neuropsychologiques, la thérapie cognitivo-comportementale, les 
facteurs prédictifs, comorbidité, anxiété, dépression 
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ABSTRACT 
 
Background: Despite substantial evidence supporting the general efficacy of cognitive behavioral 
therapy for obsessive-compulsive disorder (OSD), there is controversy about improvement in some 
neuropsychological deficits in this disorder. Objective: The present study aim to evaluate: 1) 
correlation of severity of OCD and neuropsychological test scores and 2) clinical and 
neuropsychological improvement of patients with OCD who have successfully completed their 
treatment. Method: This study evaluates neurocognitive function and clinical condition of 27 
participants of OCD group and 25 participants of control group. The neurocognitive function of every 
participant has been assessed using Rey-Osterreich Complex Figure Test (RCFT), D-KEFS fluency 
test and Cardebat- D test. We also, used Beck Anxiety Inventory (BAI), Beck Depression Inventory 
(BDI) and Yale-Brown Obsessive-Compulsive scale(Y-BOCS) to verify comorbidity of anxiety and 
depression with OCD and severity of symptoms in patients with OCD. Results: Our study 
concludes that a significant difference of function in copy score is present between OCD and control 
group. Also, we found considerable difference in score of immediate and delayed recall of RCFT 
before and after treatment in OCD group. Conclusion: In summary, the present study 
demonstrated that OCD patients have specific cognitive impairments and cognitive behavioral 
therapy could improve, at least, some neurocognitive dysfunction. 
Keywords: OCD, Neuropsychological tests, Cognitive behavioral therapy, Predictors, 
Comorbidity, Anxiety, Depression 
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CHAPTER 1 
INTRODUCTION 
 
Obsessive-compulsive disorder (OCD) is a potentially chronic disabling condition characterized by 
recurring, intrusive, anxiety-provoking thoughts or images (obsessions) associated  with repetitive, 
physical or mental rituals (compulsions)  performed to relieve anxiety (28,68).An individual must 
exhibit  either obsessions or compulsions to meet DSM-IV-TR criteria(65) lasting more than one hour 
per day and have sufficient severity to cause marked distress or impairment (13).Patients with both 
obsessions and compulsions constitute at least 75 per cent of the affected patients, with most 
patients presenting with multiple obsessions and compulsions (22). The symptoms are typically 
recognized as being excessive or unrealistic, although insight may be limited in some adults and 
especially in children with the disorder (64).   
 The symptom presentation of OCD is heterogeneous. Factor and cluster analytical studies 
of symptom measures, such as the Yale Brown Obsessive Compulsive Scale(Y-BOCS), have 
identified a number of symptom dimensions that tend to be relatively stable over time within 
individuals.  These include repeatedly washing hands or other parts of the body to free oneself from 
imagined contamination; repeated checking behaviors to ensure that nothing has been forgotten or 
missed that may result in harm to oneself or others; excessive concern with order or symmetry; and 
hoarding (64). Obsessions pertaining to religious, sexual or aggressive themes or health concerns 
are also reported. Obsessional doubt may manifest itself as slowness, indecisiveness, or rumination 
without any overt compulsion. It should be noted that while compulsive hoarding is currently listed 
as a symptom of OCD, there is evidence suggesting that it may represent a distinct subgroup or 
syndrome (64).  
   However obsessions and compulsions can also be found in a mild non clinical form in most 
individuals to a varying degree. In reality, obsessions and compulsions aren‘t exclusive to OCD (13). 
OCD is associated with significant disruption of psychosocial functioning, reduced quality of life in 
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patients and their relatives, as well as considerable economic cost to the individual and society. This 
is particularly concerning given the typically lengthy period of time taken by people with OCD to 
seek treatment (64). 
Presenting problems among children and adolescents with OCD generally resemble the 
adult presentation. However, compared to adults, children are more likely to deny impairment (65). 
 
1.2. Prevalence and incidence 
 
For a long time  researchers considered OCD rare but different studies show that this disorder is the 
fourth most prevalent mental illness after major depression, drug abuse and panic disorder (62). 
Studies show it can affect as many as 2-3% of children (48) and up to 3% population of many 
cultures (60, 82, 67). Also, the ECA (Epidemiological Catchment Area) study suggested that its 1-
month and 6-month prevalence is 1.3% and 1.5%, respectively (26).While some authors believe this 
prevalence is underestimated(67,2) others believe it is an overestimation(4).Clark (13)believes it is 
reasonable to place the lifetime prevalence for OCD between 1 and 2  % of the general population. 
 The incidence of OCD in women is higher than in men (3, 31), although men typically have an 
earlier age of onset than women (13).But, OCD is more common in males in pediatric samples (64). 
Different studies show that women displaying more washing and cleaning rituals and men have 
more sexual obsessions than women (40, 70).Usually this disorder start in childhood or adolescence 
and the symptoms will continue for many years (79). First-degree relatives of people with OCD are 
at considerably greater risk for developing the disorder than the general population.  The onset of 
idiopathic OCD is typically insidious, although precipitating or stressors events such as childbirth 
have been reported (64). Age of onset has been reported to be bimodal, with one peak between 10 
and 12 years of age and a second peak in the early to mid-20s (16). Age of onset may be especially 
relevant to the etiology and  treatment of OCD as early onset has been associated with male 
gender predominance, greater symptom severity, a higher rate of tic disorders, poorer response to 
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treatment, and a greater likelihood of having a family history of OCD (64). OCD is chronic in most 
individuals. A meta-analysis of 22 longitudinal studies involving a total of 521 children with OCD, 
with follow-up periods ranging from 1 to 15.6 years, reported a persistence rate of 41% for full OCD 
and of 60% for full or subthreshold OCD (64). 
 
1.3. Comorbidity 
 
OCD often co-occurs with other mental disorders. Up to 75% of individual with OCD have at least 
one additional current disorder(13).The most common comorbid disorders seen with OCD are  
anxiety disorder such as panic disorder and simple and social phobia, mood disorder, eating 
disturbance, tic disorder, depression,  autism, and Tourette‘s syndrome, schizophrenia,  alcoholism 
and substance abuse (85 ,61, 26). Epidemiologically, the OCD comorbidity risk for other major 
psychiatric disorders was found to be fairly high but nondistinctive (30). In a clinical sample of 
schizophrenic and schizoaffective patients, about 8% met criteria for OCD, highlighting the 
importance of screening for obsessive-compulsive symptoms in such populations where detection 
may be more difficult (26). 
In childhood, psychiatric disorder co-occurring with OCD is the norm rather than exception. It 
has been estimated that as many as 50 percent of pediatric patients with OCD have two or more 
co-occurring diagnosis. The most common comorbid disorders include other anxiety disorders, 
depressive disorders, tic disorders, attention-deficit/hyperactivity disorder (ADHD), and disruptive 
behavior disorders (65). 
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1.4. Etiology and Classification 
 
Until recently, the most common view was that OCD should be classified as an anxiety disorder (9) 
but some researchers have challenged this opinion (75, 19). Some believe that OCD is a belief 
disorder (49), while other authors suggest that it is better to categorize this disorder as a schizotypal 
disorder (18).Based on ICD-10 and DSM-5 classification, OCD is categorized separately from 
anxiety disorders as an independent category (76, 17). 
The etiology of OCD remains unclear although both early socialization experiences and 
neurophysiological factors seems to contribute to its development (49) .Parental rearing style in 
particular dimensions of parental affection and parental control have been associated with OCD (23). 
Researchers have categorized between four to seven subtypes of OCD (80, 81, 58, 59). The two 
most common symptom types, compulsive washing and checking, account for the majority of OCD 
cases (13). A large scale study of Rasmussen and Eisen was based on more than 1000 patients 
with OCD. Ranked from most common to least common, the subtypes are fear of contamination 
(50%), pathologic doubt (42%), somatic (33%), need for symmetry/precision (32%), aggression 
(31%) or sex (24%) and religious/blasphemy (10%). Regarding compulsions, the most common are 
checking (61%) and washing/cleaning (50%). Other types consist of, need to ask/confess (34%), 
symmetry/precision (28%) and hoarding (18%) (58, 59).  
 
1.5. Treatments 
 
The most established pharmacological treatment option for OCD patients is selective serotonin 
reuptake inhibitors, alone or in combination with other medications and cognitive behavior therapy 
such as exposure/response prevention therapy(ERP) (5, 20, 43). 
 Cognitive-behavioral therapies of OCD include the inference-based approach (IBA) and the 
cognitive appraisal model (CAM) (53) .The first behavioral therapy method developed was ERP. It 
includes prolonged exposure to obsessional cues and strict prevention of rituals (76). There are 
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different versions of this method varying in duration, frequency and manner of exposure. The 
cognitive appraisal model proposes that unwanted intrusive thoughts are a universal experience, 
but if they are appraised as holding negative implications for the person, the person will become 
preoccupied and try to ‗‗neutralize‘‘ or otherwise suppress the thought,  so maintaining the 
preoccupation with the thought(51). This method of treatment focus on faulty appraisals and beliefs 
of control, therefore; the goal of treatment is to guide the client toward termination of all activities 
that are aimed at reducing the frequency of the obsession and its associated distress (13).This 
method is  usually carried and in combination with ERP. 
IBA considers that in OCD the initial intrusion is actually an inference; hence it is part of the 
obsession. The initial doubt is considered the primary inference and is maintained by an 
idiosyncratic reasoning process that leads to the doubting inference, which subsequently spirals 
into secondary aversive consequences or secondary inferences. The IBA model does not detract 
from the important clinical role of appraisals, but instead of viewing the content of all intrusions as 
unproblematic, the inference- based approach conceptualizes ‗‗intrusions‘‘, particularly those in 
OCD with overt compulsions, as inferences or propositions arrived at and at some point formed 
through inductive reasoning processes(51). In fact, the inference-based approach (IBA) to treating 
OCD offers a reasoning perspective on obsessional ideation. IBA focuses on reasoning narratives 
producing the initial doubting inference in OCD. Its claim is that no matter what the form of the 
OCD, the obsessional chain always begins with a doubting inference arrived at through a reasoning 
process termed inferential confusion. Inferential confusion has two components: (a) an investment 
in remote (often imaginary) possibilities in preference to reality and (b) a distrust of the senses and 
common sense. Together these two components confuse the person with OCD into inferring doubt 
in the absence of a valid basis for such doubt (53). 
The aim of inference-based therapy (IBT), then, is to invalidate the reasoning producing the 
primary (doubting) inference and return the person to the world of the senses and common sense, 
which they were led to disbelieve and mistrust by the invalid reasoning narrative (52). 
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The IBT protocol is organized in a series of cumulative stages. The major steps are: 
1. Establish the nature of the obsessional doubt and educate in distinguishing obsessional                    
doubt from authentic doubt. 
2. Unravel the subjective ―story‖ (reasoning narrative) behind the primary inference. 
3. Illustrate how the doubt goes against perception in the here and now and detracts from    
common sense. 
4. Reveal clearly how reasoning devices lead to an arbitrary doubting inference. 
5. Examine the power of the imagination. 
6. Utilize techniques to return the person to the senses and common sense (such as constructing 
an alternative realistic narrative, grounding the person in reality sensing). 
7. Return the person to the world of the senses. 
8. Finally, target the vulnerable-self theme (53). 
Currently, IBT is delivered in a twelve-step format for the duration of 24 one-hour sessions 
utilizing worksheets, exercise sheets and training cards in accordance with published guidelines. 
The therapy has been modified to a short-term format by two experts in IBT, in particular with 
respect to time-lines, and how long the therapists are expected to work en each step of the program 
up to a total of 12 one-hour sessions. Otherwise, however, both short-term and long-term therapy 
will be identical in terms of the components and steps addressed during treatment (52). 
 For those for whom these therapies are not effective, psychosurgery may afford significant 
symptom relief. In particular, recent research has supported the use of deep brain stimulation for 
OCD in at least some otherwise treatment-refractory patients (64).In this study, our participants 
received inference-based approach (IBA). 
 
1.6. Neurocognitive and neuropsychological impairment  
 
OCD has been the subject of numerous neuropsychological investigations since the late 1980s (64). 
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There are considerable neurocognitive and neuropsychological impairment in patients with 
OCD (32). There is evidence of improvement in some neuropsychological deficits in OCD, such as 
set shifting, planning, organizational strategies, flexible self-guided behavior and problem-solving 
following CBT and pharmacological treatments (38, 35). Other findings show that neuropsychological 
and cognitive impairment do not improve even after successful treatment, such as nonverbal 
memory, initiation of spontaneous or self-guided thought/action and controlled attention,  immediate 
and delayed recall, inhibitory control and verbal fluency(35,78).  
It has been estimated that up to 50% of patients either do not benefit from therapy 
intervention or drop out (72, 46).The researchers and authors have determined different factors that 
could influence treatment outcomes. 
 Jakubovski et al (2012) report that the presence of obsessions with sexual and religious 
content, as well as older age at admission have been associated with a poorer prognosis. But, they 
believe that there is no consistent relationship between other factors such as gender, age at onset, 
level of insight, psychiatric comorbidity including comorbid tic disorders, pattern of response to 
short-term treatment, baseline severity of symptoms, and presence of psychiatric family history with 
long-term outcome treatment. Other studies show that although, demographic variables and 
comorbidity are predictors of outcome, there is no systematic relationship between 
neuropsychological measures and outcome treatment. These inconsistencies might be due to use 
of different populations, different medications or severity of OCD. It could also be that improvement 
in psychological variables such as confidence rather than neuropsychological performance 
produces changes in neuropsychological measures (57). 
Additionally, there is the uncertainty about the influence of neurocognitive condition of 
patients on treatment response. D‘Alcante et al (2012) show that higher baseline 
neuropsychological performance predicted better treatment response to both treatments, with the 
exception of mental flexibility. But, at least three studies didn‘t find significant neuropsychological 
differences at baseline assessment between overall responders and non-responders (8, 78, 46). 
8 
 
One of the most common limitations of these studies is the small sample size (36, 14, 51). In 
addition, patients who drop out during treatment, the difficulty to relate change to individual 
components of the dimension of the Y-BOCS and OCD severity (28), co morbidity with other 
disorders (56, 14), ethnic restriction of participants (36), the lack of consistency in the report of age of 
onset of OCD (42) are other limitations that could affect reliability and accuracy of studies. 
 
1.7. Aims of study 
 
The aim of our study is to examine the predictors of outcome on treatment of OCD in patients 
diagnosed with OCD with or without of comorbidities before and after they have completed 24 
weeks of psychotherapy with varying degree of symptom remission. This study helps us to identify 
predictors relevant to treatment outcome. In fact, the objective of our study is twofold: 1) to evaluate 
correlation of severity of OCD and neuropsychological test scores; and 2) to evaluate clinical and 
neuropsychological improvement of patients with OCD who have successfully completed their 
treatment. 
  
 
1.8. Research question 
 
We will explore: 1) if there is a relationship between OCD symptomatology and Visio-Spatial 
function, non-verbal memory and verbal and non-verbal fluency performance; and 2) whether or not 
psychotherapy will improve the performance of patients on these tasks. Outcome will be measured 
using the Yale Brown Obsessive Compulsive Scale (Y-BOCS). 
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CHAPTER 2 
METHOD  
 
2.1. Recruitment 
 
The study involves analysis of data collected from studies previously approved by an ethics 
committee. All patients were referred by clinician experts in evaluation and treatment from the 
Centre d‘étude sur le spectre obsessif-compulsif et les tics (CÉTOCT) between September 2008 
and October 2011. Following the telephone screening, an appointment was made with evaluator for 
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), after which a psychologist and a 
neuropsychologist made a thorough assessment. The SCID-I is a semistructured interview for 
making the major Axis I DSM-IV-TR diagnoses. It is administered by a clinician and includes an 
introductory overview followed by nine modules, seven of which represent the major axis I 
diagnostic classes. This method guides the clinician in testing diagnostic hypotheses as the 
interview is conducted (69). 
Twenty-five normal controls were recruited through advertising within the Institut universitaire 
en santé mentale de Montréal and some journal of Montreal. All participants, OCD and control 
groups, were recruited from the greater Montreal region. The first interview was by telephone, in 
which we explained the criteria of study and asked participants if they had psychiatric disorder. The 
participants who had the necessary condition and criteria came to the institute to sign ethically 
approved consent forms and fill the questionnaires.  
Entry criteria were: (a) primary diagnosis, according to DSM-IV-TR criteria of OCD,(b)no 
other principal axes1 disorders requiring treatment, (c) no change  in medication type or dose 
during the 12 weeks before treatment for antidepressants(4 weeks for anxiolytics), (d) willingness to 
keep medication stable while participating in the study, (e) no evidence of suicidal intent, (f) no 
evidence of current substance abuse, (g) no evidence of current or past schizophrenia, bipolar 
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disorder or organic mental disorder, (h) willingness to undergo active psychological treatment, (i) 
willingness to undergo randomization into treatment modality, and (j) fluency in either English or 
French. In the interests of generalisation of results and establishing clinical effectiveness of results, 
the entry criteria do not exclude a secondary (comorbid) diagnosis on axis I or II providing it does 
not require treatment or is deemed unlikely to significantly affect compliance with the current 
treatment plan. 
Medication-Participants with medication who enter the treatment program were assessed by 
one of the team psychiatrists specialized in the pharmacological treatment of anxiety disorders. If 
antidepressant medication has not been stable for at least 12 weeks, a stabilization period was 
imposed. Other medications (e.g., anxiolytics) were stable for at least four weeks. Participants with 
stable medication were accepted if they meet diagnostic and severity criteria for OCD for entry once 
the stabilization period has elapsed. Medication levels were self-monitored throughout and at follow-
ups. Participants and prescribing physicians were asked to avoid modification whenever possible, 
and to inform the therapist if changes were unavoidable. Participants might change, reduce or 
eliminate medication following post-treatment evaluation. 
 
2.2 Procedure 
 
 The OCD group was matched to a control group that consist of 14 women (56%) and 11 men (44% 
p=0,817) on sex, age, intelligence (Raven&WAIS) and handedness (Edinburg) to ensure 
comparability of mental capacity between groups.  
The purpose of Raven's progressive matrices is to assess reasoning in the visual modality. 
The standard test consists of 60 items grouped into five sets, each set containing 12 items. Each 
item contains a pattern problem with one part removed and six to eight pictured inserts, one of each 
contains the correct pattern (72). 
The purpose of the WAIS test is to provide a measure of general intellectual function in older 
adolescents and adults. It is a core instrument, giving information about the overall level of 
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intellectual functioning and the presence or absence of significant intellectual disability. The WAIS 
contains a total of 14 subsets. The examiner asks test questions, displays pictures or puzzles to the 
patient, and records the patient‘s responses in an individual response booklet (74).   
A ten-item questionnaire designed to assess handedness by self-report of the preferred hand 
for carrying out common activities such as writing and drawing, throwing, and using utensils such as 
a toothbrush, knife, and spoon. Participants place 1 or 2 check marks under "left" or "right," 
indicating strength of preference for each activity; 2 checks are to be used if the individual "would 
never try to use the other hand unless absolutely forced to" for the given function.  As some 
activities require the use of both hands, the directions specify which component reflects hand 
preference . A laterality quotient can be calculated where a score of 100 reflects complete dextrality, 
and a score of −100 is obtained by complete sinistrals (54).  
Because all tasks were visual and colored, we confirmed normal visual acuity (Snellen) and 
color perception (Ishihara). We will explain Ishihara test in instruments and measures section. 
Therapy was conducted in either English or French depending on the participant preference. 
All therapies were delivered on an individual weekly basis up to a maximum of 24 weeks. Previous 
research by our team has been shown that the best predictor of outcome at 24 weeks is clinical 
improvement at 13 weeks. This finding allows us to decide on best treatment options for all 
participants at 13 weeks. Participants undertook the therapy course of 24 weeks on the 
understanding that completion of the course requires continual and regular attendance at weekly 
sessions. In the case of a participant showing non-clinical status prior to 24 weeks, attendance was 
continued up to 24 weeks. At 24 weeks, if the person showed minimal improvement they were 
referred elsewhere to suitable resources. All parameters of treatment delivery were identical across 
treatment modalities. Principal outcome measures were evaluated at pre and post-treatment.  
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2.3 Participants  
 
Our clinical groups consist of 16 women (59, 25%) and 11 men (40, 75%) with mean age of 
40,67±13,61years old and our control group include 14 women (56%) and 11 men (44% ) with 
mean age of 35,12±12,74. 
Different subtypes of our participants can be found in Table 1. 
 
 
Table1.The number and percentage of OCD participants based on their subtype 
Subtype Number Percentage 
Aggressive 5 18,51 
Checking 5 18,51 
Contamination 5 18,51 
Hoarding 5 18,51 
Body dysmorphic 6 22,22 
somatic 1 3,07 
 
 
2.4. Instruments and measures  
 
An interview assessed participants according to DSM-IV-TR and on personal history and severity of 
OCD symptom rating using the Yale Brown Obsessive Compulsive Scale (Y-BOCS). Also, we used 
the anxiety and depression questionnaire to assess comorbidity with these disorders. 
 
2.4.1 Yale-Brown Obsessive-Compulsive scale 
 
 The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) is a 10-item clinician-rated scale that 
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assesses the severity of obsessions and compulsions independent of the type or number of 
symptoms (13). Each item rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total 
possible score range from 0 to 40. The scale includes questions about the amount of time the 
patient spends on obsessions, how much impairment or distress they experience, and how much 
resistance and control they have over these thoughts. The same types of questions are asked 
about compulsions (e.g., time spent, interference, etc.) as well. The results can be interpreted 
based on the total score. A total score of 0-7 is interpreted as a "Subclinical "OCD; 8-15 as "Mild"; 
16-23 as "Moderate", 24-31 as "Severe" and 32-40 as "extreme" OCD. 
Different studies (55, 24) illustrate that this test has good internal consistency, convergent 
validity and discriminant validity. For example, Pertusa et al (2012) show that in their study 
Cronbach‘s alphas and P value for different dimensions were between 97 and 99 and less than 0.01 
respectively. 
Refractoriness to treatment in OCD includes a decrease less than 35% on the Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS) total score at final evaluation as compared to baseline or a 
final score of >16 on the Y-BOCS (5).  
 
2.4.2 Beck Anxiety Inventory 
 
 The Beck Anxiety Inventory (BAI) is a 21- item multiple-choice self-report inventory that measures 
the severity of an anxiety in adults and adolescents. Because the items in the BAI describe the 
emotional, physiological, and cognitive symptoms of anxiety but not depression, it can discriminate 
anxiety from depression. Each of the items on the BAI is a simple description of a symptom of 
anxiety in one of its four expressed aspects: (1) subjective (e.g., "unable to relax"), (2) 
neurophysiologic (e.g., "numbness or tingling"), (3) autonomic (e.g., "feeling hot") or (4) panic-
related (e.g., "fear of losing control"). Respondents are asked to report the extent to which they 
have been bothered by each of the 21 symptoms in the week preceding (including the day of) their 
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completion of the BAI. Each symptom item has four possible answer choices: Not at All; Mildly (It 
did not bother me much); Moderately (It was very unpleasant, but I could stand it), and; Severely (I 
could barely stand it). The clinician assigns the following values to each response: Not at All = 0; 
Mildly = 1; Moderately = 2, and; Severely = 3. The values for each item are summed yielding an 
overall or total score for all 21 symptoms that can range between 0 and 63 points. A total score of 0-
7 is interpreted as a "Minimal" level of anxiety; 8-15 as "Mild"; 16-25 as "Moderate", and; 26-63 as 
"Severe" (6). 
 
2.4.3 Beck Depression Inventory 
 
The Beck Depression Inventory (BDI) is a 21 -item; multiple-choice self-report ratings inventory that 
measures characteristic attitudes and symptoms of depression. This questionnaire is composed of 
items relating to symptoms of depression such as hopelessness and irritability, cognitions such as 
guilt or feelings of being punished, as well as physical symptoms such as fatigue, weight loss, and 
lack of interest in sex. When the test is scored, a value of 0 to 3 is assigned for each answer and 
then the total score is compared to a key to determine the depression's severity. The standard cut-
offs are as follows: 0-9 indicates minimal depression, 10-18 mild, 19-29 moderate and 30-63 severe 
depression (7).  
 
2.4.4 Ishihara 
 
The Ishihara Color Test is an example of a color perception test for red-green color deficiencies. 
The test consists of a number of colored plates, called Ishihara plates, each of which contains a 
circle of dots appearing randomized in color and size. Within the repetition pattern are dots which 
form a number or shape clearly visible to those with normal color vision, and invisible, or difficult to 
see, to those with a red-green color vision defect, or the other way around. The full test consists of 
38 plates, but the existence of a deficiency is usually clear after a few plates. There is also the 
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smaller test consisting only 24 plates (27). 
 
2.4.5 Edinburgh Handedness Inventory 
 
The Edinburgh Handedness Inventory is a measurement scale used to assess the dominance of a 
person's right or left hand in everyday activities, sometime referred to as laterality. The inventory 
consist questions about the more obvious unilateral activities such as writing and drawing. The set 
of answers obtained may be regarded as a structured, standardised description of the individual‘s 
handedness characteristics (54). 
 
2.5. Neuropsychologic tests and measures 
 
 The following tests were administered: Cardebat-D test to evaluate non-verbal fluency, D-Kefs test 
to check verbal fluency and Rey figure test to evaluate Visio spatial and memory of participants. 
 
2.5.1 Rey-Osterreich Complex Figure Test 
 
Rey-Osterreich Complex Figure Test (RCFT) is administered to evaluate visio-spatial integration, 
planning, organizational skills, problem solving, motor functioning, perceptual and memory abilities. 
This task includes a copy condition, a 3 minutes immediate recall and a 30 minutes delayed recall 
condition.  
The figure was placed in front of the subjects, who were requested to copy the figure as 
accurately as possible and inform the examiner when they had finished. When the copying of the 
figure was completed the stimulus was removed from sight. After a 3-minute delay participants were 
asked to reproduce the figure from memory (without forewarning). In the delay-period verbal fluency 
tests were applied. The figure can be separated into 18 different units. For scoring (both copy and 
recall) two points were given if an element was correctly reproduced. One point was given when the 
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reproduction was distorted, incomplete but placed correctly or complete but placed in incorrect 
location. A score of 0.5 points was given if an element was placed in an incorrect location and 
distorted/incomplete. Not recognizable elements were given a score of zero. 
Based on the quality of the copy, subjects were divided into two groups. Incomplete copy 
score (scores below 34) and faultless copy score (scores of 34 and above). This split variable was 
computed to evaluate recall performance based on the quality of the copy. The cut-off score of 34 
was chosen because many people make minor mistakes when copying and a score of 34 would still 
allow one item from the figure to be missed (45).  
The response time and the accuracy for each condition were scored by one independent 
neuropsychologist blind to the participant‘s diagnosis. Internal and Test-Retest reliability of this test 
is high. Both split-half and coefficient alpha reliabilities were greater than 0.60 for the copy condition 
and greater than 0.80 for recall condition. Also, the percentage agreement in the clinical 
interpretation between the first and second testing session was 91.7(74). 
 
2.5.2 D-KEFS fluency test 
 
We used D-KEFS fluency test to evaluate non-verbal fluency. The objective of this test is to 
examine the integrity of executive functions by assessing the client's ability to make different 
designs, assessing response inhibition and cognitive flexibility. The participant must make the 
greatest possible different designs for 1 min. We use a sheet containing rows of squares filled 
points in the protocol. Three conditions are: 
Condition 1: that the participant drew connecting points between them filled by the rules 
Condition 2: that the participant drew connecting only empty points  
Condition 3:  that the participant switched between full and empty points to make different 
designs. The validity of this test for non-verbal fluency isn‘t high but it is acceptable and with a 
score about 0.59(74). 
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2.5.3 Cardebat- D test 
 
Cardebat-D is a French version of verbal fluency evaluation. Because our participants were English 
and French speaking, we used both versions of this test. It is a simple test of language production. 
The selected lexical evocation tests involve oral lexical items corresponding to three semantic 
criteria production and three formal. Each of these subtests is assigned a time of 2 minutes; the 
productions are recorded and analyzed at the time of transcription in four blocks of 30 seconds per 
subtest. The order of execution is random and three semantic criteria are: "Animals" considered rich 
items, "Furniture" items considered poor and "Fruits" considered intermediate. For lexical fluency, 
we ask the participants to say as many words as possible beginning with the letters P, R and V. A 
lexical and categorical fluency sufficient in clinical routine to get an idea. Although, several 
researchers have used this test to evaluate verbal fluency in diverse population and performance 
norms exist, there is little information about the validity of this test (10). 
 
2.6. Statistical analysis 
 
The data were analyzed using the Statistical Package for Social Sciences (SPSS; Version 8.0). 
Analysis of scores for normality revealed that the all neuropsychological variables except two were 
normatively distributed and hence parametric test (t- test) was employed. We used non-parametric 
test (Mann-Whitney Test) for variable of verbal fluency and handedness for data that were not 
normally distributed. First question was tested by correlation of analysis clinical scores on Y-BOCS 
compared with the neuropsychological tests using  Pearson‘s product-moment correlation, 
assuming parametric distribution of scores or Spearman‘s rank correlation for non-parametric. 
Bonferroni correction controlled for multiple comparison. 
 In line with our first hypothesis, we compared by t-test pre-treatment information between 
OCD and control participants who completed the same neuropsychological tests as the OCD group 
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between September 2006 and June 2013. We also, established differences on neuropsychological 
tests within the OCD group alone in relation to symptom severity.     
For the second question we computed analysis of variance on repeated neuropsychological 
and clinical measures pre-post treatment.  
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CHAPTER 3 
RESULTS 
 
3.1 Demographic and functional characteristics 
 
 Table 2 summarizes the demographic and functional characteristics of the OCD and control group. 
The OCD patients and the controls did not differ significantly in demographic and functional 
characteristics such as age, educational level, gender, visual acuity, color perception and 
handedness. 
Table 2.Demographic and functional characteristics of the OCD patients and normal controls 
 
Variables OCD(n=27) 
Mean   SD 
Controls(n=25) 
Mean        SD 
P-value 
 
T-Test 
 
Age 40, 67      13, 61 35, 12      12, 74 0,136 1,514 
Education 
(years) 
14, 03       2, 86 13, 36      2, 03 0,328 0,988 
Age of onset 15, 25       9, 68    
Duration of 
illness (year) 
25, 41      14, 9    
Visual Acuity 1, 09         0, 15 1, 08        0,21 0,806 0,247 
Color Perception 10, 77       0, 42 10, 68      0,69 0,538 0,621 
Handedness 
(Mean Rank) 
25, 93 27, 12 0,482 -0,703(Z) 
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3.2. Clinical assessment 
 
Ten patients had minimal anxiety (37, 03%) while eight participants with OCD had mild anxiety (29, 
62%). In addition, 6 and 3 patients suffered from moderate and severe anxiety, respectively (22, 
22% and 11, 11%). Based on depression questionnaire, we found that one patient suffered from 
severe depression (3, 7%) and three of the clinical group had moderate depression (11, 11%). Also, 
twelve and eleven patients had minimal and mild depression, respectively (44, 44% and 40, 74%). 
Nineteen member of control group had minimal anxiety (76%) and six of them suffered from mild 
anxiety (24%). In our control group, we didn‘t find the participants with mild or more severe 
depression but, twenty four participants had minimal depression (96%). 
Table 3  shows the results of pretreatment and control group of anxiety and depression 
questionnaires .The OCD patients were found to be more depressed (14, 89±8,25, p<0,001) and 
anxious (12,52±9,73, p=0,001) as evaluated by BDI and BAI. It shows that those with OCD have 
elevated levels of depression and anxiety as compared to controls. 
 
 
Table3.Comparison of anxiety and depression questionnaire score in the OCD group and 
control group 
 
Disorder OCD(n=27) 
Mean   SD 
Controls(n=25) 
Mean      SD 
P-Value T-Test 
Anxiety 12,52     9,73 5,04    4,80 0,001 3,552 
Depression 14,89    8,25 3,08    3,91 <0,001 6,669 
 
 
Based on Y-BOCS scores, we found that one patient had mild OCD (3, 7%) and eight of them had 
moderate OCD (29, 62%). Also, fourteen and four persons of our participants had severe and 
extreme OCD, respectively (51, 85% and 14, 81%). 
The results of anxiety, depression and Y-BOCS questionnaires in OCD group, before and 
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after treatment, are shown in table 4. This table shows that the treatment reduced the severity of 
OCD symptoms and the severity of anxiety and depression as comorbid disorders. Although, there 
is a significant difference between score of Y-BOCS before and after treatment, however twelve 
participants‘ posttreatment score remeasured greater than 16. In addition, the score of one patient 
with OCD reduced less than 35% posttreatment. 
 
Table4.Comparison of anxiety, depression and Y-BOCS questionnaire score before and after 
treatment in OCD group 
 
Disorder Pre-treatment 
Mean     SD 
Post-treatment 
Mean      SD 
P-Value T-Test 
Anxiety 12, 52      9, 73 9, 30        8, 44 0,009 2,842 
Depression 14, 89       8, 25 10, 33      8, 22 0,001 
 
3,675 
Y-BOCS 25, 81       5, 80 15, 22      6, 38 <0,001 7,643 
 
3.3. Neuropsychological tests 
 
Scores on pretreatment and control group assessment of neuropsychological tests and for all 
participants are shown in Table 5. 
There were significant and near significant differences between OCD and control group on 
the following tests: Rey figure copy score (p=0,007), time of copy score (p=0,042), immediate recall 
(p=0,055), time of immediate recall (0,052), delay recall (p=0,067) and time of delay recall 
(p=0,092). 
But, we didn‘t find considerable differences on D-kefs test(non-verbal fluency) condition1 
(p=0,777), condition2 (p=0,922), condition3 (p=0,117), Cardebat-D test(verbal fluency), P 
word(p=0,325), R word(p=0,247), V word(p=0,712), animal word(p=0,572), fruit word(0,706) and 
furniture word(p=0,178). Also, we didn‘t find a significant difference between OCD group and control 
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group on WAIS test (p=0,164) and Raven test (p=0,382). 
 
Table 5.Comparison of performance on neuropsychological tests in the OCD group and control 
group 
 
Neuropsychological 
variable value 
OCD(n=27) 
Mean    SD 
Controls(n=25) 
Mean        SD 
P-Value t-Test 
Raven 24,14       4,35 25,12    3,50 0,382 -0,882 
WAIS 17,40       2,97 18,68     3,52 0,164 -1,41 
D-kefs 
 
    
First Condition 10, 26     2, 79 10,00    3,25 0,777 0,285 
Second Condition 12, 59     3, 50 12,50    2,30 0,922 0,099 
Third condition 8, 85       2, 99 10,28    2,82 0,117 -1,600 
Rey figure 
 
    
Copy Score 31, 44     2, 43 33,54      2,97 0,007 -2,788 
Time of copy Score 180, 04   88, 33 140,84    36,97 0,042 2,114 
Immediate Recall 18, 94     6, 54 22,38      6,02 0,055 -1,963 
Time of Immediate 
Recall 
155, 78   90, 39 118,40    32,15 0,052 2,017 
Delayed Recall 18, 25      6, 41 21,46      5,85 0,067 -1,873 
Time of Delayed 
Recall 
121, 48    64, 21 98,36      25,20 0,092 1,732 
Cardebat-d 
 
    
P Words 23, 44      5, 38 22,08   4,40 0,325 0,995 
R words 20, 78      5, 44 19,00   5,49 0,247 1,171 
V words 18, 78      4, 23 18,78   4,23 0,712 0,371 
Animal Words 28, 96      5, 66 29,92   6,45 0,572 -0,570 
Fruits Words(Mean 
Rank) 
27,26 25,68 0,706 -0,378(Z) 
Furniture (Goods) 
Words 
17, 50      4, 41 15,92   3,81 0,178 1,365 
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 Descriptive statistics for outcomes at baseline and posttretament can be found in Table 6. 
When baseline results compared with posttreatment situation, no differences were detected in the 
majority of tests. In fact, we see significant difference, just, in score of immediate and delayed recall 
of Rey Figure test (P=0, 034, P=0,032 respectively).  
 
 
Table6.Comparison of performance on neuropsychological tests before and after treatment in 
the OCD group  
 
Neuropsychological 
variable value 
pre-treatment 
Mean    SD 
post-treatment 
Mean        SD 
P-Value t-Test 
D-Kefs 
 
    
First Condition 10,35        2,61 11,33         2,66 0,290 -1,099 
Second Condition 12,33        4,04 12,40         3,48 0,945 -0,070 
Third condition 8,80         3,50 8,87           3,24 0,910 -0,115 
Rey figure     
Copy Score 30,83        1,90 32,06        3,29 0,094 -1,797 
Time of copy Score 165,47      76,53 153,60      70,03 0,496 0,699 
Immediate Recall 18,90         7,22 23,26        5,64 0,034 -2,344 
Time of Immediate 
Recall 
155,33      64,70 152,80      64,63 0,855 0,186 
Delayed Recall 18,43         7,03 22,73        6,31 0,032 -2,374 
Time of Delayed 
Recall 
115,87       46,13 111,60      45,78 0,671 0,434 
Cardebat-D 
 
    
P Words 23,33         4,43 23,07         3,93 0,838 0,209 
R words 21,67         4,25 21,33         3,41 0,632 0,490 
V words 18,67         3,77 20,13          4,20 0,175 -1,427 
Animal Words 28,73         4,92 28,93          3,75 0,871 -0,166 
Fruits Words 20,40         4,13 21,73         3,19 0,186 -1,390 
Furniture (Goods) 
Words 
18,50         5,51 17,64         3,45 0,472 0,741 
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Also, we used Pearson test to look at correlations between Y-BOCS score that shows 
severity of OCD symptoms and neuropsychological tests. Table 7 illustrates these results. We 
found significant correlation between Y-BOCS scores and time of copy score in Rey figure test and 
P words and Animal words of Cardebat-d test. While correlation is positive in the first test, it is 
negative in second and third test. 
 
 
Table7. Correlation of Y-BOCS score with neuropsychological tests 
 D-Kefs 
 
 First Condition Second Condition Third Condition 
Y_BOCS R                    P 
0,015             0,941 
R                P 
-0,133           0,510 
R                  P 
-0,367           0,060 
 
 
Table7.(Continued) 
 Rey figure 
 Copy Score Time of copy 
Score 
Immediate 
Recall 
Time of 
Immediate 
Recall 
Delayed 
Recall 
Time of 
Delayed 
Recall 
Y_BOCS R      P 
-0,046   0,821 
R       P 
0,401   0,038 
R       P 
-0,267 0,178 
R       P 
0,204  0,308 
R       P 
-0,218  0,276 
R        P 
0,260  0,190 
 
 
 
Table7.(Continued) 
 Cardebat-D 
 
 P Words R words V words Animal 
Words 
Fruits 
Words 
Furniture 
Words 
Y_BOCS R      P 
-0,481    0,011 
R      P 
-,196    0,327 
R      P 
-,224   0,262 
R      P 
-,0410  0,034 
R      P 
-,503  0,793 
R      P 
0,002  0,994 
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CHAPTER 4 
DISCUSSION 
4.1 Objective and resume of study 
We investigated the neuropsychological profile in a sample of OCD subjects and healthy controls 
using a comprehensive battery of neuropsychological tests. The OCD group and the healthy control 
group (HCG) were comparable on age, years of education and gender composition. Patients with 
OCD didn‘t show significant poorer performance on tasks of visuospatial working, non-verbal 
memory, general intelligence, verbal and non-verbal fluency comparing to control group. The only 
significant difference between these groups was in copy score and the time that participants took to 
do this part of Rey complex figure test. The RCFT has been widely employed as a measure of 
visuospatial constructional ability and visuospatial memory (35). Meyers and Meyers (1995), further, 
insisted that RCFT permits assessment of such cognitive processes as planning, organizational 
skills and problem-solving as well as perceptual, motor and memory functions (54). The precise 
cognitive operations required for adequate RCFT performance are known to include visual 
perception, visuospatial organization, motor functioning and, on the recall conditions, memory (35).  
Chiulli et al. (1995) suggested that conditions of copy, immediate and delayed recall provide 
different information. They declare that while the copy condition reflects perceptual, visuospatial and 
organizational skill, the immediate recall reflects the amount of information that is encoded. 
Furthermore, the delayed recall condition reflects the amount of information that is stored and 
retrieved from memory (11). Mathews et al (2001) believe that impaired organizational strategy 
scores are due to focal frontal lesion and temporal lobe lesion could cause a recall impairment 
(44).Another study (Choi et al 2003) shows that the volume of the left anterior subregion of the  
orbitofrontal cortex(OFC) was positively correlated with the RCFT copy score(13 ).In addition, at 
least two studies claim that organization during  a copy trial is a strong predictor for the subsequent 
immediate and delayed recall performance, since  the organizational process of memory is crucial 
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for efficient encoding and retrieval of information (15, 21). Also, it has been suggested that individuals 
with OCD do not have ‗true‘ memory deficits. In fact, they do not forget encoded material, but have 
difficulty utilizing organizational strategies in order to encode effectively (32). 
 There is considerable evidence in the literature for the presence of non-verbal memory 
deficits in OCD (77, 32, 47, 39) but the present study doesn‘t support previous findings completely. 
In our study, relative to healthy controls, patients with OCD weren‘t shown to have impaired 
memory functioning on non-verbal immediate and delayed recall tests; but, the performance of OCD 
patients in the copy score was less than of control group. In addition, on comparison of pre and post 
treatment findings, there was a difference. While our patients had a considerable improvement in 
immediate and recall score with psychotherapy, some researchers didn‘t report this finding (8, 21). 
 Our results could suggest that psychotherapy improves not only encoding information but 
also storing and retrieving information. 
The D-KEFS consists of a set of nine tasks designed to assess the component processes of 
executive functioning.  We used one subgroup of this test to evaluate non-verbal fluency of our 
participants. Several studies have documented that performance on the D-KEFS, including non-
verbal fluency, is adversely affected by frontal lobe lesion. To our knowledge, unlike verbal fluency, 
the majority of researchers didn‘t evaluate this task in OCD patients. Although, the finding of 
previous research supported our own findings (37), others reported inferior performance in OCD 
group comparing with controls (77). Kuelz et al (2006) reported significant difference between OCD 
and control group on this task but, they used the Five-Point test to assess non-verbal fluency (38). 
Verbal fluency assesses the spontaneous oral generation of words based on phonemic 
(phonemic fluency) or semantic criteria (semantic fluency). In general, phonemic fluency has 
been thought to be associated with frontal-lobe function, while semantic fluency has been 
thought to be associated with temporal-lobe function (66). The majority of researchers have used 
other tests (I.e. COWA) in order to evaluate this function.   
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Bolton et al (2000) claim that they found a significant difference between OCD and control in 
verbal fluency in their study. Roh et al (2005) and Kim et al (2002) added that the results of their 
study are in agreement with the view that the cognitive dysfunctions associated with verbal fluency 
remain despite the clinical improvement. The present study doesn‘t support this idea because 
relative to healthy controls, the OCD group didn‘t demonstrate impaired verbal fluency. 
Greisberg et al (2003) didn‘t find a relationship between the experimental measures and 
severity of symptoms as measured by the Y-BOCS (26) but, unlike it, Tallis et al (1999) have shown 
a significant relationship between recognition memory problems and immediate memory for actions 
with general symptom severity (77). 
In a meta-analysis by Kuelz and his colleagues (2004), they report that out of 22 
neurocognitive investigations elucidating the role of symptom severity, most commonly assessed 
with the Yale Brown Obsessive-Compulsive Scale; 9 studies found no correlation between symptom 
severity and cognitive functioning and contrary to expectation, some authors found a positive 
correlation between neuropsychological functioning and symptom severity (40). 
Although, our study shows a significant correlation between 3 tests and severity of OCD 
symptoms, we didn‘t find this correlation in the majority of our tests. 
Based on Y-BOCS score, we found that cognitive-behavioural treatment had the effect of 
reducing symptoms for all participants. It is in the agreement with five earlier studies (28, 38, 8, 42, 63) 
but, some article have claimed that psychotherapy hasn‘t been effective (73).  
The data from our sample illustrates that OCD patients are more anxious and depressed 
than control healthy participants. These results are broadly consistent with extant research (32, 35, 38, 
28). Research on the impact of co-morbid psychiatric problems on neuropsychological functioning in 
OCD has focused almost exclusively on depression, typically examining correlations between 
performances on continuous measures such as the Beck Depression Inventory.  Several such 
studies have reported that depression contributes to deficits in OCD on measures such as those 
tapping executive functions, memory and verbal fluency (64). This finding raises an important 
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question. What percentage of these defects is due to depression and how much caused by OCD? 
Next studies might answer to this question.Yap et al (2012) state that comorbid depression is a 
predictor of poor treatment response in OCD (84) but, the present study illustrates that treatment has 
reduced OCD symptoms and severity of depression and anxiety. These data are compatible with 
some studies (35, 63). 
 
6. Limitation 
 
This study must be interpreted in the light of some limitations. As with other studies conducted in 
this area, an important limitation to this study is small sample size. Also, some patients didn‘t come 
back to repeat neuropsychological test after treatment. Using, just three neuropsychological tests is 
the third limitation of this study, therefore; we didn‘t evaluate all neurocognitive functions. 
 
7. Recommendation 
 
As we already mentioned, we used three neuropsychological tests in order to evaluate 
neurocognitive function of our participant. We believe that our results need to be replicated with a 
larger participant‘s sample especially for the Cardebat-D test that researchers have used less than 
other tests. Also, if other researchers use other neuropsychological tests, we could have clearer 
image of the extent of neurocognitive dysfunction of patients with OCD. In addition, more controls 
on the influence of comorbid disorders on cognitive function of patients with OCD are necessary.  
 
 
 
 
 
29 
 
 
 
CHAPTER 5 
CONCLUSION 
 
The present research is one of only a handful of studies examining the neuropsychological tests for 
predicting the outcome of treatment in OCD. In summary, the present study demonstrated that OCD 
patients have specific cognitive impairments. Compared with the controls, the OCD patients showed 
their cognitive deficits in copy score and the time that they took to do this part of the Rey complex 
figure test. The neuropsychological profile in OCD patients obtained from the present study isn‘t 
consistent with some other studies. To conclude, the findings suggest that OCD patients with 
neurocognitive impairment can benefit from cognitive-behavioral therapy, because this therapy 
improves at least, some neurocognitive dysfunction. 
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Appendix A 
 Beck anxiety inventory 
Below is a list of common symptoms of anxiety. Please carefully read each item in the list. 
Indicate how much you have been bothered by that symptom during the past week, including 
today, by writing an ―X‖ in the corresponding space in the column next to each symptom. 
 
Not At All Mildly  
but it didn‘t 
bother me 
much 
Moderately 
It wasn‘t 
pleasant at 
times 
Severely 
It bothered me 
a lot 
1. Numbness or tingling     
2. Feeling hot     
3. Wobbliness in legs      
4. Unable to relax      
5. Fear of worst happening     
6. Dizzy or lightheaded     
7. Heart pounding/ racing     
8. Unsteady     
9. Terrified or afraid     
10. Nervous     
11. Feeling of choking     
12. Hands trembling     
13. Shaky / unsteady     
14. Fear of losing control     
15. Difficulty in breathing     
16. Fear of dying     
17. Scared     
18. Indigestion     
19. Faint / lightheaded     
20. Face flushed     
21. Hot/cold sweats     
X 
 
Appendix B 
 
Beck Depression Inventory 
 
This questionnaire consists of 21 groups of statements.  Please read each group of statements 
carefully, and then pick out the one statement in each group that best describes the way you 
have been feeling during the past two weeks, including today. Circle the number beside the 
statement you have picked. If several statements in the group seem to apply equally well, circle 
the highest number for that group. Be sure that you do not choose more than one statement for 
any group, including Item 16 (Change in Sleeping Pattern) or Item 18 (Change in Appetite). 
 
1. 0    I do not feel sad. 
 1    I feel sad much of the time. 
 2 I am sad all the time. 
 3 I am so sad or unhappy that I can‘t stand it. 
 
2. 0 I am not discouraged about my future. 
 1 I feel more discouraged about my future than I used to be. 
 2 I do not expect things to work out for me. 
 3 I feel my future is hopeless and will only get worse. 
 
3. 0 I do not feel like a failure. 
 1 I have failed more than I should have. 
 2 As I look back, I see a lot of failures. 
 3 I feel I am a total failure as a person. 
 
4. 0 I get as much pleasure as I ever did from the things I enjoy. 
 1 I don‘t enjoy things as much as I used to. 
 2 I get very little pleasure from things I used to enjoy. 
 3 I can‘t get any pleasure from the things I used to enjoy. 
 
XI 
 
5. 0 I don‘t feel particularly guilty. 
 1 I feel guilty over many things I have done or should have done. 
 2 I feel quite guilty most of the time. 
 3 I feel guilty all of the time. 
 
6. 0 I don‘t feel I am punished. 
 1 I feel I may be punished. 
 2 I expect to be punished. 
 3 I feel I am being punished. 
 
7. 0 I feel the same about myself as ever. 
 1 I have lost confidence in myself. 
 2 I am disappointed in myself. 
 3 I dislike myself. 
 
8. 0 I don‘t criticize or blame myself more than usual. 
 1 I am more critical of myself than I used to be. 
 2 I criticize myself for all of my faults. 
 3 I blame myself for everything bad that happens. 
 
9. 0 I don‘t have any thoughts of killing myself. 
 1 I have thoughts of killing myself, but I would not carry them out. 
 2 I would like to kill myself. 
 3 I would kill myself if I had the chance. 
 
10. 0 I don‘t cry anymore than I used to. 
 1 I cry more than I used to. 
 2 I cry over every little thing. 
 3 I feel like crying, but I can‘t 
 
11. 0 I am no more restless or wound up than usual. 
 1 I feel more restless or wound up than usual. 
 2 I am so restless or agitated that it‘s hard to stay still. 
 3 I am so restless or agitated that I have to keep moving or doing something
   
XII 
 
 
12. 0 I have not lost interest in other people or activities. 
 1 I am less interested in other people or things than before. 
 2 I have lost most of my interest in other people or things. 
 3 It‘s hard to get interested in anything. 
 
13. 0 I make decisions about as well as ever. 
 1 I find it more difficult to make decisions than usual. 
 2 I have much greater difficulty in making decisions than I used to. 
 3 I have trouble making any decisions. 
 
14. 0 I don‘t feel worthless. 
 1 I don‘t consider myself as worthwhile and useful as I used to. 
 2 I feel more worthless as compared to other people. 
 3 I feel utterly worthless. 
 
15. 0 I have as much energy as ever. 
 1 I have less energy than I used to have. 
 2 I don‘t have enough energy to do very much. 
 3 I don‘t have enough energy to do anything. 
 
16. 0 I have not experienced any change in my sleeping pattern. 
 1a I sleep somewhat more than usual. 
 1b I sleep somewhat less than usual. 
 2a I sleep a lot more than usual. 
 2b I sleep a lot less than usual. 
 3a I sleep most of the day 
 3b I wake up 1-2 hours early and can‘t get back to sleep. 
 
17. 0 I am no more irritable than usual. 
 1 I am more irritable than usual. 
 2 I am much more irritable than usual. 
 3 I am irritable all the time. 
 XIII 
 
 
 
18. 0 I have not experienced any change in my appetite. 
 1a My appetite is somewhat less than usual. 
 1b My appetite is somewhat greater than usual. 
 2a My appetite is much less than before. 
 2b My appetite is much greater than usual. 
 3a I have no appetite at all. 
 3b I crave food all the time. 
 
19. 0 I can concentrate as well as ever. 
 1 I can‘t concentrate as well as usual. 
 2 It‘s hard to keep my mind on anything for very long. 
 3 I find I can‘t concentrate on anything. 
 
20. 0 I am no more tired or fatigued than usual. 
 1 I get more tired or fatigued more easily than usual. 
 2 I am too tired or fatigued to do a lot of the things I used to do. 
 3 I am too tired or fatigued to do most of the things I used to do. 
 
21. 0 I have not noticed any recent change in my interest in sex. 
 1 I am less interest in sex than I used to be. 
 2 I am much less interest in sex now. 
 3 I have lost interest in sex completely 
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Appendix C 
 
Y-BOCS Symptom Checklist 
 
Date: ...................  Evaluator:....................................... 
Check all that apply, but clearly mark the principal symptoms with a ‗P‘ and must ascertain whether reported 
behaviours are bona fide symptoms of OCD and not symptoms of other disorders such as Simple Phobia or 
Hypochondriasis.  
 
 
 AGGRESSIVE OBSESSIONS Current Past  
1. Fear might harm self   
2. Fear migth harm others   
3. Violent or horrific images   
4. Fear of blurting out obscenities or insults   
5. Fear of doing something else embarrassing    
6. Fear will act on unwanted impulses (e.g. stab a friend)   
7. Others (specify)   
    
 HONNESTY AND MAKING A MISTAKE OBSESSIONS Current  Past 
8. Fear will steal things (a bank, shoplifting, or ‗cheating‘ a cashier)   
9. Fear will harm others because not careful enough (e.g. hit and run)   
10. Fear will be responsible for something else terrible happening (e.g. fire, 
burglary) 
  
11. Others (specify)   
    
 CONTAMINATION OBSESSIONS Current Past 
12. Concerns or disgust with bodily waste or secretion (e.g. urine, feces, saliva)   
13. Concern with dirt or germs   
14. Excessive concern with environmental contaminants (e.g asbestos, radiation, 
toxic waste) 
  
15. Excessive concern with household items (e.g. cleansers, solvents)   
16. Excessive concerns with animals (e.g. insects)   
17. Bothered by sticky substances or residues   
18. Concerned will get ill because of contaminant   
19. Concerned will get others ill by spreading contaminant   
20. No concern with consequences of contamination other than how it might feel   
21. Others (specify) 
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 SEXUAL OBSESSIONS Current Past 
22. Forbidden or perverse sexual thoughts, images, or impulses    
23. Content involves children or incest   
24. Content involves animals   
25. Content involves homosexuality   
26. Aggressive sexual behaviours toward others   
27. Others (specify)   
 
 HOARDING/SAVING OBSESSIONS Current Past 
28. (specify) 
 
  
    
 RELIGIOUS OBESSIONS (SCRUPULOSITY) Current Past 
29. Concerned with sacrilege and blasphemy   
30. Excess concern with right/wrong, morality   
31. (specify) 
 
  
    
 OBSESSION WITH NEED FOR SYMMETRY OR EXACTNESS Current Past 
32. What are the consequences? Accompanied by magical thinking (e.g. 
mother will be in an accident unless things are in the right place) 
  
33. Not accompanied by magical thinking   
34. (specify) 
 
  
    
 MISCELLANEOUS OBSESSIONS Current Past 
35. Need to know or remember   
36. Fear of saying certain things   
37. Fear of not saying just the right thing   
38. Fear of losing things   
39. Intrusive (non-violent) images   
40. Intrusive nonsense sounds, words, or music   
41. Bothered by certain sounds/noises   
42. Lucky or unlucky numbers   
43. Colours with special significance   
44. Supersticious fears   
45. Others (specify) 
 
  
    
 SOMATIC OBSESSIONS Current Past 
47. Excessive concerns with body part or aspect of appearance    
48. Others (specify) 
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 CLEANING/WASHING COMPULSIONS Current Past 
49. Excessive or ritualized handwashing   
50. Excessive or ritualized showering, bathing, toothbrushing, 
grooming, or toilet routine 
  
51. Involves cleaning of household items or other inanimate objects   
52. Other measures to prevent contact with contaminants   
53. Other measures to remove contact with contaminants   
54. Others (specify) 
 
  
 
 CHECKING COMPULSIONS Current Past 
55. Checking doors, locks, stove, electrical appliances, hand-brake in 
the car, etc.  
  
56. Checking that did not/will not harm others   
57. Checking that did not/will not harm self   
58. Checking that nothing terrible did/will happen   
59. Checking that did not make mistake   
60. Checking tied to somatic obsessions   
61. Others (specify) 
 
  
    
 REPEATING RITUELS Current Past  
62. Re-reading or re-writing   
63. Need to repeat routine activities (in/out the door, up/down from 
chair, etc.) 
  
64. Others (specify) 
 
  
    
 COUNTING OBSESSIONS Current Past 
65. (specify) 
 
  
    
 ORDERING AND ARRANGING OBESSIONS Current Past 
66. (specify) 
 
  
    
 HOARDING/COLLECTING COMPULSIONS Current Past  
67. (specify) 
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 MISCELLANEOUS COMPULSIONS Current Past 
68. Excessive listmaking   
69. Need to tell, ask, or confess   
70. Need to touch, tap, or rub   
71. Rituals involving blinking or staring   
72. Measures to prevent : harm to self   
73.                                     harm to others   
74.                                     terrible consequences   
75. Ritualized eating behaviours   
76. Superstacious behaviours   
79. Others (specify) 
 
  
 
 MENTAL COMPULSIONS Current Past 
80. Words, images, or special numbers that are used to neutralize   
81. Special prayer (short or long) that are repeated in a specific set way   
82. Mental counting   
83. Mental listmaking   
84. Review back mentally (like playing back a movie)   
85. Others (specify)   
 
 NEUTRALIZATION (Due to your thoughts about..., do you ever...) Current Past 
86
. 
Reassure self by telling one‘s self certain things (e.g. it is not as bad 
as it seems, don‘t overreact)? 
  
87
. 
Reassurance-seeking from a loved-one, from others (E.g. friends, 
family, doctors, etc.)? 
  
88
. 
Take part in a mental act or a concrete action in order to get rid of the 
thought? What?  
  
89
. 
Ponder carefully about the thought (e.g. find solutions, analyze)?   
90
. 
Replace the thought by thinking about something else (e.g. more 
positive things, or others)? 
  
91
. 
Distract one‘s self with surrounding (e.g. arranging a frame, things on 
the desk)? 
  
92
. 
Throw one‘s self into activities (e.g. housework, TV, work, sport)?   
93
. 
Tell one‘s self ‗STOP‘ or something similar (e.g. that‘s enough)?   
94
. 
Do nothing with the thought (e.g. let it roam free, not get preoccupied, 
thought leaves by itself without any strategy)? 
  
95
. 
Others (specify)   
 XVIII 
 
 
 
 AVOIDANCE (Due to your thoughts or compulsions, have you 
ever avoided...) 
Current Past 
96. Places (e.g. hospitals, schools)?   
97. Objects (e.g. a knife)?   
98. People (e.g. a friend, a teacher, a group of individuals)?   
99. To do things (e.g. avoided peeling potatoes)?   
100. Certain types of information (e.g. a movie, a report, the news)?   
101. Interpersonal situations (e.g. if people around me talk about cancer I 
leave)? 
  
102. Others (specify)   
 
 
 
Target Symptom List 
Date: ...................  Evaluator:....................................... 
 
Obsessions 
 
Problem 1:          _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________  
 
Problem 2:          _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 3:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 4:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Compulsions (Mental compulsions included) 
 XIX 
 
 
 
Problem 1:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________  
 
Problem 2:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 3:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 4:         _______________________________________________________________ 
__________________________________________________________________________________
______________________________________________________________________________ 
   
XX 
 
 
 
Neutralization (Do not include mental compulsions) 
 
Problem 1:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________  
 
Problem 2:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 3:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 4:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
 
Avoidance 
Problem 1:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________  
 
Problem 2:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
 
Problem 3:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
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Problem 4:         _______________________________________________________________ 
__________________________________________________________________________________
________________________________________________________________________________ 
   
   
XXII 
 
 
 
  
 
 
 YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS) 
Revised version 
 
Date:...................  Evaluator:....................................... 
 
 
 
Obsessions 
 
1. Time occupied by obsessive 
thought 
None Mild Moderate Severe Extreme 
  0 1 2 3 4 
1.b Obsession-free interval (not 
included in sub-total scores) 
None Long Moderately 
long 
Short Extremely 
short 
  0 1 2 3 4 
       
2. Interference due to 
obsessive thoughts 
0 1 2 3 4 
       
3. Distress associated with 
obsessive thoughts 
0 1 2 3 4 
       
4. Resistance against 
obsession 
Complete 
resistance 
   Yields 
completely 
  0 1 2 3 4 
       
5. Degree of control over 
obsessions 
Complete Much Moderate Little None 
  0 1 2 3 4 
Sub-total for obsessions (add items 1 to 5): _______ 
 
Compulsions 
 
C6. Time spent performing 
compulsive behaviours 
None Mild 
 
Moderate 
 
Severe 
 
Extreme 
 
  0 1 2 3 4 
       
C6.
b 
Compulsion-free interval (not 
included in sub-total scores) 
None Long Moderately 
long 
Short Extremely 
short 
  0 1 2 3 4 
       
C7. Interference due to 
compulsive behaviours 
0 1 2 3 4 
       
C8. Distress associated with 
compulsive behaviours 
0 1 2 3 4 
       
   
   
XXIII 
 
 
C9. Resistance against 
compulsions 
Complete 
resistance 
   Yields 
completely 
  0 1 2 3 4 
       
C10
. 
Degree of control over 
compulsive behaviours 
Complete Much Moderate Little None 
  0 1 2 3 4 
Sub-total for compulsions (add items C6 to C10): _______ 
   
 
XXIV 
 
 
Neutralization 
 
N6. Time spent on neutralization None Mild 
 
Moderate 
 
Severe 
 
Extreme 
 
  0 1 2 3 4 
       
N6.
b 
Neutralization-free interval  None Long Moderately 
long 
Short Extremely 
short 
  0 1 2 3 4 
       
N7. Interference due to 
neutralization 
0 1 2 3 4 
       
N8. Distress associated with 
neutralization 
0 1 2 3 4 
       
N9. Resistance against 
neatralization 
Complete 
resistance 
   Yields 
completely 
  0 1 2 3 4 
       
N10
. 
Degree of control over 
neutralization 
Complete Much Moderate Little None 
  0 1 2 3 4 
Sub-total for neutralization (add items N6 to N10): _______ 
 
Avoidance 
 
E6. Degree of avoidance None Little Moderate Important Extremely 
important 
  0 1 2 3 4 
       
E6.b Avoidance-free interval None Long Moderately 
long 
Short Extremely 
short 
  0 1 2 3 4 
       
E7. Interference due to 
avoidance 
0 1 2 3 4 
       
E8. Distress associated with 
avoidance 
0 1 2 3 4 
       
E9. Resistance againsts 
avoidance 
Complete 
resistance 
   Yields 
completely 
  0 1 2 3 4 
       
E10. Degree of control over 
avoidance 
Complete Much Moderate Little None 
  0 1 2 3 4 
Sub-total for avoidance (add items E6 to E10): _______ 
 
11. Insight into obsessions and 
compulsions 
Excellent    
Absent 
  0 1 2 3 4 
       
   
XXV 
 
12. Avoidance  None  Little  Moderate  Important Extremely 
important 
  0 1 2 3 4 
       
13. Degree of indecisiveness 0 1 2 3 4 
       
14. Overvalued sense of 
responsability 
0 1 2 3 4 
       
15. Pervasive slowness 0 1 2 3 4 
       
16. Pathological doubting 0 1 2 3 4 
         
17. Global 
severity 
None Slight Mild Moderate Moderate-
severe 
Severe Extremely 
severe 
  0 1 2 3 4 5 6 
         
18. Global 
improvement 
Extremely 
worse 
Much 
worse 
Minimally 
worse 
No change Minimally 
improved 
Much 
improved 
Very much 
improved 
  0 1 2 3 4 5 6 
       
19. Reliability Excellent Good Fair Poor  
  0 1 2 3  
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